In final analysis, J&J's underdog vaccine offers only 52.9% protection against Covid-19
It’s long been established that the single-shot vaccine produced by J&J is nowhere near as effective as two doses of the mRNA vaccine — initially viewed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
